Fast Facts

Company name: Douglas Pharmaceuticals Limited
Company address: Central Park Drive, Henderson, Auckland
Date established: 1967
Chairman: Sir Graeme Douglas MNZM FPS
Managing Director: Jeff Douglas
Chief Financial Officer: Kent Durbin
Chief Scientific Officer: Mark Fletcher
Chief Operating Officer: Rod de Spong
Chief Commercial Officer: Scott Sherriff
Number of employees: 450


Product expertise:

  • High potency/containment manufacturing of softgel capsules, tablets, hard gelatin capsules, semisolids (e.g. retinoids, anticancer, immunosuppressants, steroids, Vitamin D analogues)
  • Microencapsulated API (Active Pharmaceutical Ingredient) products (e.g. retinoids)
  • Novel formulations
  • New strengths for existing products


Product Presentation   Strength Condition  
Acitretin capsule   10mg, 17.5mg, 22.5mg Psoriasis  
Anastrozole tablets   1mg Breast Cancer  
Azathioprine film coated tablets   25 mg, 50 mg, 75 mg, 100 mg Immunosuppressant  
Bicalutamide filmcoated tablets   50mg Prostrate Cancer  
Clozapine tablets   25 mg, 50 mg, 100 mg, 200 mg Schizophrenia  
Clozapine suspension   50mg/ml Schizophenia  
Cyproterone acetate tablets   50mg, 100mg Prostate Cancer  
Dutasteride softgel capsules   0.5mg Benign Prostatic Hypertrophy  
Ethinylestradiol/cyproterone acetate tablets   35mcg/2mg    
Exemestance tablets   25mg Breast Cancer  
Isotretinoin softgel capsules   5mg, 10mg, 20mg, 30mg, 40mg Severe Acne  
Letrozole tablets   2.5mg Breast Cancer  
Paricalcitol softgel capsules   1,2mcg Hyperparathyroidism  
Quetiapine tablets   25mg, 100mg, 200mg, 300mg Schizophrenia  
Risperidone tablets   0.5mg, 1mg, 2mg, 3mg, 4mg, 6mg Schizophrenia  
Rivastigmine capsules   1.5mg, 3mg, 4.5mg, 6mg Alzheimers Disease  


* Licensing Conditions Apply

History snapshot

  • Founded in 1967, Douglas Pharmaceuticals was initially a marketer and distributor of ethical and over-the-counter (OTC) medicines in New Zealand. In the 1980s the company began manufacturing generic pharmaceuticals for the local market.
  • In the 1990s, as a consequence of New Zealand health sector reforms, Douglas increased its focus on export activities. This move resulted in the restructuring of core operations into two distinct business activities: domestic in-licensing and agency operations, to supply the New Zealand retail pharmacy sector own and in-licensed generics, OTC’s and nutraceutical/dietary supplements; and export out-licensing operations, to supply generic medicines and dietary supplements to global markets.
  • Douglas Pharmaceuticals’ domestic operation has grown to more than $57 million annually and today employs one of the largest field sales teams in New Zealand. The sales team services retail pharmacy, health stores, hospitals, doctors and specialists.
  • Currently we are supplying close to 30 generic products to more than 60 customers in 35 countries around the world.